Work

Cabozantinib in high-grade neuroendocrine neoplasms.

Year: 2026

Type: conference-abstract

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.2026.44.16_suppl.4183

Authors: Nikolaos Trikalinos, Rama Suresh, Katrina Sophia Pedersen, Belal Firwana, Melissa A. Reimers, Paul Tracy Mehan, Anjali Rohatgi, Esther Lu, Olive Pressey, Nicholas Waldron, Shuang Wu, Benjamin R. Tan

Institutions: Washington University in St. Louis, Mayo Clinic, Mayo Clinic Comprehensive Cancer Center (Minnesota), Heartland Cancer Research, Alvin J. Siteman Cancer Center

Language: English

Topic: Neuroendocrine Tumor Research Advances

Subfield: Epidemiology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

Funders: Foundation for Barnes-Jewish Hospital, Exelixis

Award: G4229268078

OpenAlex ID: W7162493039

Cites:

Cited by:

Related to: